Rothfuss Cristin - Insider Non-Derivative Transactions at Sarepta Therapeutics, Inc. (SRPT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 28, 2025, Rothfuss Cristin's relationship to Sarepta Therapeutics, Inc. (SRPT) is Officer (EVP, General Counsel), and currently has 139,756 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SRPT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Rothfuss Cristin - Insider Non-Derivative Transactions of SRPT Common Stock

Rothfuss Cristin - Insider Non-Derivative Transactions at SRPT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 29, 2025	F -- (Common Stock)	229	21.12	139756
Sep 4, 2025	Acquisition -- (Common Stock)	93875	0	114985
Sep 4, 2025	Acquisition -- (Common Stock)	25000	0	139985
Mar 11, 2025	F -- (Common Stock)	491	100.13	12834
Mar 11, 2025	Acquisition -- (Common Stock)	8276	0	21110
Mar 8, 2025	F -- (Common Stock)	347	103.7	11847
Mar 8, 2025	F -- (Common Stock)	1131	103.7	12194
Mar 5, 2025	F -- (Common Stock)	288	101.34	13037
Mar 5, 2025	F -- (Common Stock)	296	101.34	13325
Mar 4, 2025	F -- (Common Stock)	391	103.77	13621
Nov 27, 2024	Acquisition -- (Common Stock)	2000	0	13817